Abdominal obesity is a risk factor in cardiovascular disease

被引:0
作者
Valdes Quintana, Eduardo [1 ]
Garro, Noemi [2 ]
机构
[1] Univ Salvador, RA-1056 Buenos Aires, DF, Argentina
[2] Univ Buenos Aires, Buenos Aires, DF, Argentina
来源
SALUD I CIENCIA | 2010年 / 18卷 / 01期
关键词
cardiovascular risk; obesity; adipose tissue; adipokines; adiponectin; ADIPONECTIN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Obesity is a disease of increasing incidence and prevalence world wide, defined as a body mass index (BMI) greater than 25 (weight Kg/height squared). In recent years body fat distribution has begun to be seen as the element most related to cardiovascular risk, taking hip waist index greater than 0.90 in males and 0.80 in females, as parameters for defining central abdominal obesity. Obesity, in particular abdominal obesity, is currently considered an important quantitative and modifiable cardiovascular risk factor, while adipose tissue is considered an endocrine organ that through the liberation of cytokines (adipocytokines) and hormones regulates the energy and calorie balance, affecting cardiovascular risk.
引用
收藏
页码:18 / 21
页数:4
相关论文
共 16 条
[1]   Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial [J].
Esposito, K ;
Pontillo, A ;
Di Palo, C ;
Giugliano, G ;
Masella, M ;
Marfella, R ;
Giugliano, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1799-1804
[2]   New perspectives on atherogenesis role of abnormal triglyceride-rich lipoprotein metabolism [J].
Ginsberg, HN .
CIRCULATION, 2002, 106 (16) :2137-2142
[3]  
Gregory L, 2008, ARCH INTERN MED, V168, P928
[4]   Adipose tissue as an endocrine organ [J].
Kershaw, EE ;
Flier, JS .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2548-2556
[5]  
Kralisch S, 2007, ENDOCRINOL MINERVA, V32, P161
[6]   Association of hypoadiponectinemia with coronary artery disease in men [J].
Kumada, M ;
Kihara, S ;
Sumitsuji, S ;
Kawamoto, T ;
Matsumoto, S ;
Ouchi, N ;
Arita, Y ;
Okamoto, Y ;
Shimomura, I ;
Hiraoka, H ;
Nakamura, T ;
Funahashi, T ;
Matsuzawa, Y .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (01) :85-89
[7]   The delicate balance between fat and muscle: adipokines in metabolic disease and musculoskeletal inflammation [J].
Nawrocki, AR ;
Scherer, PE .
CURRENT OPINION IN PHARMACOLOGY, 2004, 4 (03) :281-289
[8]   Plasma adiponectin levels and risk of myocardial infarction in men [J].
Pischon, T ;
Girman, CJ ;
Hotamisligil, GS ;
Rifai, N ;
Hu, FB ;
Rimm, EB .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (14) :1730-1737
[9]   Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers [J].
Rothenbacher, D ;
Brenner, H ;
März, W ;
Koenig, W .
EUROPEAN HEART JOURNAL, 2005, 26 (16) :1640-1646
[10]   Adiponectin-mediated modulation of hypertrophic signals in the heart [J].
Shibata, R ;
Ouchi, N ;
Ito, M ;
Kihara, S ;
Shiojima, I ;
Pimentel, DR ;
Kumada, M ;
Sato, K ;
Schiekofer, S ;
Ohashi, K ;
Funahashi, T ;
Colucci, WS ;
Walsh, K .
NATURE MEDICINE, 2004, 10 (12) :1384-1389